MedTrace Logo

Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)

NCT00417378 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2007-11-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of a left ventricular assist device in comparison to a standard treatment with an intraaortic balloon pump (IABP) in patients with cardiogenic shock due to left ventricular failure following an acute coronary syndrome (myocardial infarction).

Conditions

Interventions

DEVICE

Left Ventricular Assist Device Impella LP 2.5

Left Ventricular Assist Device

DEVICE

Intraaortic Balloon Pump

Counterpulsation

Sponsors & Collaborators

  • Abiomed Inc.

    collaborator INDUSTRY

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Melchior Seyfarth, MD · Deutsches Herzzentrum Muenchen

  • Josef Dirschinger, MD · 1. Medizinische Klinik, Klinikum rechts der Isar

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Completion
2006-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00417378 on ClinicalTrials.gov